HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Clinical trials for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart failure drug tested for hidden benefits beyond the heart
Disease control CompletedThis study tested whether the heart failure drug vericiguat improves the health of patients' blood vessels and reduces body-wide inflammation. It involved 26 adults with chronic heart failure who were already on standard treatments. Researchers measured blood vessel function, wal…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: PHASE4 • Sponsor: Josef Stehlik • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Novartis tests new shot for weakened hearts
Disease control CompletedThis early-stage study tested the safety and side effects of a new drug called XXB750 for people with chronic heart failure. It involved 27 participants who received either the drug or a placebo via injection. The main goal was to see how well the drug was tolerated and how it mo…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Feb 19, 2026 14:37 UTC
-
Scientists hunt for better clues to predict heart failure survival
Knowledge-focused CompletedThis study looked back at the medical records of 4,000 heart failure patients to see if combining information from common blood tests and heart scans could better predict a patient's risk of dying within one year. The goal is to help doctors make more accurate, personalized risk …
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Sponsor: Xinjiang Medical University • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:52 UTC